NCT00551798View on ClinicalTrials.gov

Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Hodgkin's DiseaseMalignant Lymphomas High GradeChemoresistance
Interventions
PROCEDURE

TEP au MIBI

Intravenous injection of MIBI.The review lasted 30 min, during which the patient should not move.

Trial Locations (5)

87042

Anatomo-pathology, Limoges

Hematology, Limoges

Nuclear Medicine, Limoges

Pharmacology, Limoges

Radiology, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER

NCT00551798 - Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade | Biotech Hunter | Biotech Hunter